Clinical Trials on Hepatobiliary Malignancies in United Kingdom
Total 864 results
-
Medical University of South CarolinaCompletedColorectal Surgery | Hepatobiliary SurgeryUnited States
-
Mayo ClinicNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingMalignant Hepatobiliary NeoplasmUnited States
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
University of NebraskaTerminatedHepatobiliary DiseasesUnited States
-
MEI Pharma, Inc.Quotient ClinicalCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMalignant Hepatobiliary NeoplasmUnited States
-
Stanford UniversityThe American Association of Physicists in MedicineTerminatedPancreatic Cancer | Lung Cancer | Liver Cancer | Hepatobiliary Cancers | Hepatobiliary Cancers Liver | Lung Cancer Non-Small Cell Cancer (NSCLC) | Lung Cancer Small Cell Lung Cancer (SCLC) | Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) | Hepatobiliary Cancers Gallbladder | Hepatobiliary Cancers...United States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
University Hospital Southampton NHS Foundation...University of Southampton; Maastricht UniversityRecruitingHepatobiliary Cancer | Upper Gastrointestinal Disorders | Lower Gastrointestinal DisordersUnited Kingdom
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
AstraZenecaICON plcRecruiting
-
University College, LondonCompletedCD19+ Malignancies: Relapse Post-allogeneic TransplantUnited Kingdom
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
Janssen Research & Development, LLCRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Canada, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplant | Haematological Malignancies | CD56+CD3- NK CellsUnited Kingdom
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
CelgeneActive, not recruitingNeoplasms | Hematologic Malignancies | Hematologic NeoplasmUnited Kingdom, United States
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
Royal Cornwall Hospitals TrustCompletedPalliative Care | Hematologic Malignancy | Oncology | End Stage CancerUnited Kingdom
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
University College, LondonMedical Research CouncilCompletedHaematological MalignanciesUnited Kingdom
-
Nottingham University Hospitals NHS TrustNewcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...TerminatedCancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological MalignancyUnited Kingdom
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; Mount Sinai Hospital, New YorkCompletedPancreas and Hepatobiliary Cancer PatientsUnited States
-
The Christie NHS Foundation TrustRecruitingCOVID | Oncology | Haematological MalignancyUnited Kingdom
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingCholangiocarcinoma | Liver Metastases | Hepatobiliary CancerUnited States
-
Imperial College LondonUniversity of Nottingham; Nottingham University Hospitals NHS Trust; NHS Blood... and other collaboratorsCompletedAutoimmune Diseases | Haematological Malignancies | Solid Organ Transplant RecipientsUnited Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
AgennixTerminatedMalignanciesUnited States
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedLiver Cancer | Hepatobiliary Tract Adenomas and CarcinomasUnited States
-
Samuel SoTerminatedHepatitis B | Hepatitis C | Liver Cancer | Hepatobiliary Cancers | Hepatobiliary Cancers LiverUnited States
-
University College, Londonbluebird bioActive, not recruitingPost-transplant Lymphoproliferative Disease | Transplant-Related Hematologic MalignancyUnited Kingdom
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
Bristol-Myers SquibbCompletedAdvanced MalignanciesUnited States
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Pathway Therapeutics, Inc.Completed
-
Case Comprehensive Cancer CenterCompletedHepatic MalignanciesUnited States